SHANGHAI FOSUN PHARMACEUTICAL GROUP: IT AND HENAN GENUINE BIOTECH COOPERATE WITH MULTIPLE COMPANIES TO EXPAND PRODUCTION OF COVID TREATMENT AZVUDINE
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.63 CNY | +0.77% | -0.25% | -5.59% |
05-15 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
05-15 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.59% | 7.85B | |
+37.74% | 723B | |
+34.77% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.10% | 244B | |
+10.06% | 208B | |
-4.13% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Group: It And Henan Genuine Biotec…